Neutrophils promote VLA-4–dependent B cell antigen presentation and accumulation within the meninges during neuroinflammation by Parker Harp, Chelsea R. et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2019 
Neutrophils promote VLA-4–dependent B cell antigen 
presentation and accumulation within the meninges during 
neuroinflammation 
Chelsea R. Parker Harp 
Angela S. Archambault 
Matthew Cheung 
Jesse W. Williams 
Rafael S. Czepielewski 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Chelsea R. Parker Harp, Angela S. Archambault, Matthew Cheung, Jesse W. Williams, Rafael S. 
Czepielewski, Patrick C. Duncker, Aaron J. Kilgore, Aidan T. Miller, Benjamin M. Segal, Alfred H. J. Kim, 
Gwendalyn J. Randolph, and Gregory F. Wu 
Neutrophils promote VLA-4–dependent B cell antigen
presentation and accumulation within the
meninges during neuroinflammation
Chelsea R. Parker Harpa, Angela S. Archambaulta, Matthew Cheungb, Jesse W. Williamsc,1, Rafael S. Czepielewskic,
Patrick C. Dunckerd,e, Aaron J. Kilgorea, Aidan T. Millera, Benjamin M. Segald,e,2, Alfred H. J. Kimb,
Gwendalyn J. Randolphc, and Gregory F. Wua,c,3
aDepartment of Neurology, Washington University in St. Louis, St. Louis, MO 63110; bDepartment of Internal Medicine, Washington University in St. Louis,
St. Louis, MO 63110; cDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO 63110; dHoltom-Garrett Family Program
in Neuroimmunology, University of Michigan, Ann Arbor, MI 48109; and eMultiple Sclerosis Center, Department of Neurology, University of Michigan, Ann
Arbor, MI 48109
Edited by Lawrence Steinman, Stanford University School of Medicine, Stanford, CA, and approved October 14, 2019 (received for review June 24, 2019)
The success of B cell depletion therapies and identification of
leptomeningeal ectopic lymphoid tissue (ELT) in patients with
multiple sclerosis (MS) has renewed interest in the antibody-
independent pathogenic functions of B cells during neuroinflam-
mation. The timing and location of B cell antigen presentation
during MS and its animal model experimental autoimmune en-
cephalomyelitis (EAE) remain undefined. Using a new EAE system
that incorporates temporal regulation of MHCII expression by
myelin-specific B cells, we observed the rapid formation of large
B cell clusters in the spinal cord subarachnoid space. Neutrophils
preceded the accumulation of meningeal B cell clusters, and
inhibition of CXCR2-mediated granulocyte trafficking to the central
nervous system reduced pathogenic B cell clusters and disease
severity. Further, B cell-restricted very late antigen-4 (VLA-4) defi-
ciency abrogated EAE dependent on B cell antigen presentation.
Together, our findings demonstrate that neutrophils coordinate
VLA-4–dependent B cell accumulation within the meninges during
neuroinflammation, a key early step in the formation of ELT ob-
served in MS.
B cell | EAE | multiple sclerosis
Bcells are uniquely positioned to mediate multiple aspects ofcentral nervous system (CNS) autoimmunity by secreting
both pro- and antiinflammatory cytokines, producing antigen-
specific Ig, and efficiently capturing and presenting antigen to
cluster of differentiation (CD4) T cells. The concept that B cells
are integral to the pathogenesis of multiple sclerosis (MS) has
been solidified by the recent success of B cell depletion therapy
(BCDT) for both relapsing remitting (RRMS) and primary pro-
gressive (PPMS) forms of the disease (1–4). Modeling of B cell
involvement in MS using experimental autoimmune encephalo-
myelitis (EAE) has demonstrated the importance of B cell antigen
presentation (5). Moreover, EAE studies have revealed the ne-
cessity of activation-induced cytidine deaminase (AID) expression
and elevated antigen specificity by B cells, indicating a pathogenic
role for B cell antigen processing and presentation (5–7).
In MS, the presence of oligoclonal bands (OCBs) within the
cerebrospinal fluid (CSF) raises the important question of where
cognate B:T cell interactions occur during disease. Ig isolated
from the CSF of MS patients are often class-switched to
complement-activating IgG subtypes and show signs of affinity
maturation, indicative of germinal center (GC) reactions be-
tween CD4 T cells and B cells (8). Ongoing cognate interactions
within the meninges are supported by the presence of ectopic
lymphoid tissue (ELT) in a sizeable fraction of secondary pro-
gressive MS (SPMS) patients (9, 10) as well as in mice with
various forms of EAE (11–13). The association of both OCBs
(14) and ELT (10, 15, 16) with more severe disability in MS
patients suggests that antigen-specific B:T cell interactions oc-
curring locally within the CNS compartment participate in the
propagation of neuroinflammation. These features of MS also
exemplify the importance of compartmental restrictions on B
cell-mediated CD4 T cell activation in neuroinflammation and
autoimmunity.
The genesis of ELT in autoimmune diseases within the special-
ized immune CNS compartment is poorly understood. Lehmann-
Horn et al. recently found that B cell-specific deficiency in the
α4 integrin subunit of very late antigen-4 (VLA-4) reduces sus-
ceptibility to active EAE induced by human myelin oligodendro-
cyte glycoprotein (hMOG) and decreases trafficking of both Th17
CD4 T cells and macrophages to the CNS (17). Fibroblastic re-
ticular cells (FRCs) and chemokines such as CXC chemokine li-
gand (CXCL13) have been identified as retention factors within
the meninges during EAE (11, 15, 18). However, the steps initially
involved in creating a suitable meningeal space for B cell traf-
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ficking and retention, critical for ELT organization within the
specialized immune target of the CNS, have yet to be explored.
To examine the unique contributions of B cell antigen-
presenting cell (APC) function to CD4 T cell encephalitogenicity,
we developed an EAE model allowing for timed onset of disease
mediated solely by B cell antigen presentation (6). In conjunc-
tion with rapid disease onset, we now describe the formation of
large clusters of B cells within the spinal cord subarachnoid space
resembling immature ELT. The accumulation of B cells in the spinal
cord meninges was preceded by an increase in CD45hi, CD11bhi,
Ly6C-, Gr-1+ myeloid cells. These inflammatory myeloid cells pro-
moted B cell trafficking to the CNS compartment and influenced the
formation of pathogenic B cell clusters. Additionally, B cell expression
of VLA-4 was necessary for B cell accumulation and the development
of passive EAE. These data suggest that neutrophils enhance re-
cruitment or retention of B cells in an anatomic compartment that
facilitates B cell access to both antigens and autoreactive T cells.
Results
Meningeal Space Is a Niche for B Cells during EAE. To assess the
location where B cells may participate as APCs within the CNS
during EAE, we used flow cytometry to assess the frequency of B
cells in various CNS tissues. Following immunization of B6 mice
with MOG35–55, B cells were found in low frequency and de-
tected primarily in the meninges rather than the CNS tissue
parenchyma (Fig. 1A). A similar frequency and distribution of B
cells was observed in the B cell-dependent EAE model involving
active immunization of B6 mice with hMOG (Fig. 1B), which is
unlike an initial assessment of B cell numbers in these models
(19). In contrast, passive transfer of MOG-specific encephalito-
genic CD4 T cells into B6 mice or mice with selective major his-
tocompatibility complex class II (MHCII) expression by B cells with
an elevated precursor frequency of MOG-specific B cells led to a
significantly greater frequency of B cells in the CNS. In these pas-
sive EAE models, B cells were found in the spinal cord meninges in
preponderance to the CNS tissue parenchyma (Fig. 1 C and D).
These results indicate that the meningeal compartment is the pri-
mary location where B cells collect during EAE and suggest that,
given the proximity to antigenic debris and cognate CD4 T cells, B
cells could serve as potent APCs within the meninges.
We previously reported a novel EAE model, in which MHCII
expression is induced in a cell-specific as well as temporal
manner. B cells are capable of serving all antigen presentation













































































































































































































































Fig. 1. The meningeal space is a niche for B cells during EAE. The mean ± SEM of B cells in different CNS tissues analyzed by flow cytometry. WT mice
immunized with (A) MOG35–55 (n = 7, pooled from 2 different experiments) and (B) hMOG harvested 3 d post active EAE (n = 6, pooled from 2 different
experiments). (C) WT mice (n = 15, pooled from 7 different experiments) and (D) CD19-BMHCIIxIgHMOG mice (n = 12, pooled from 4 experiments) harvested 3 d
post passive EAE onset. (E) Tam-WTAPC (n = 12, pooled from 5 different experiment) and (F) Tam-BAPC mice (n = 13 mice, pooled from 6 different experiments)
treated with Tam 3 wk after CD4 T cell transfer and harvested 3 d post EAE onset. (G) Disease severity for samples from A–F at 3 d postonset. Br, Brain; Br-M,
Brain meninges; Sc, Spinal cord; Sc-M, Spinal cord meninges. (H) B220 (pink), CD3 (green), and DAPI (blue) immunofluorescence staining of spinal cords
carefully excised from recipients of encephalitogenic CD4 T cells. (Left) Spinal cord from Tam-BAPC mouse harvested 3 wk after T cell transfer without Tam
treatment. Spinal cords harvested 3 d post EAE onset from Tam-WTAPC (Middle) and Tam-BAPC (Right) mice treated with Tam 3 wk after CD4 T cell transfer.
Images are taken at 4× magnification and are representative of n = 7 to 8 mice per genotype, pooled from 4 separate experiments. (Scale bars, 100 μm.)



















































is narrowed on the T cell cognate antigen (MOG) resulting from
IgHMOG expression (20). Using this system to examine the critical
timing of cognate interactions during neuroinflammation, the
onset of disease between Tam-WTAPC and Tam-BAPC mice
can be synchronized by inducing MHCII expression upon oral
gavage with Tam after encephalitogenic CD4 T cell transfer (20).
We showed that Tam-WTAPC mice develop passive EAE similar
to WT mice, with or without IgHMOG transgene expression,
while Tam-BAPC mice can exhibit accelerated disease onset de-
pendent on the timing of MHCII expression relative to en-
cephalitogenic T cell transfer (20). As with other models of EAE,
flow cytometric assessment of Tam-WTAPC and Tam-BAPC mice
with EAE revealed infiltration of B cells predominantly within
the spinal cord meninges (Fig. 1 E and F). No significant dif-
ference in disease severity was observed between different
models at day 3 postonset (Fig. 1G). Examination of spinal cord
tissue for the presence of B cells in Tam-WTAPC and Tam-BAPC
mice failed to identify evidence of inflammation prior to Tam
treatment of mice that had received encephalitogenic CD4 T
cells 3 wk prior to harvest. However, B220+ B cells and CD3+
T cells were evident in the spinal cords of Tam-WTAPC mice and
Tam-BAPC mice harvested 3 d post EAE onset, indicating that
MHCII+ expression is associated with the induction of lym-
phocyte trafficking to the CNS (Fig. 1E). Interestingly, B cells
appeared organized in dense clusters within the meninges in the
spinal cord sections from Tam-BAPC mice, and this pattern was
less common in Tam-WTAPC mice (Fig. 1E, arrowheads).
B Cell Clusters with Features of Rudimentary Ectopic Lymphoid
Follicles Form in the Spinal Cord of Mice with B Cell-Dependent
EAE. To investigate differences in meningeal B cell clusters in
Tam-BAPC and Tam-WTAPC mice, we quantified the volume and
number of B cell clusters. Spinal cords left intact within the
spinal column were harvested from mice 3 d after EAE onset,
optically cleared, and stained for B cells. Based on this more
exhaustive imaging method, B cell staining within the parenchyma
of the spinal cord again was rare in both genotypes. Within the
meninges, however, small clusters of B cells were observed prox-
imal to the spinal cord of Tam-WTAPC mice by confocal imaging
(Fig. 2A). In contrast, Tam-BAPC mice displayed extensive clusters
of B220+ B cells that extended several millimeters in length (Fig.
2B). Qualitatively, B cell clusters in the meninges of Tam-BAPC
spinal cords appeared denser than the diffuse B cell infiltration
seen in Tam-WTAPC mice (Movie S1). Quantifying the area and
number of distinct areas of B cell staining in cleared spinal cord
specimens, a statistically significant difference in mean voxel area
per cluster between the spinal cords of Tam-WTAPC (6857 ± 1236)
and Tam-BAPC mice (9675 ± 757) was observed (P = 0.05). Our
findings suggest that this model of EAE offers an opportunity to
explore the earliest steps involved in B cell organization leading
to ELT formation.
To gain insight into the resemblance of B cell clusters in the
spinal cord meninges to ELT, we first isolated the spinal cord
meninges of Tam-BAPC mice at 3 d post EAE onset and used
flow cytometry to analyze the composition of leukocytes. Splenocytes
harvested from an hMOG-immunized mouse were used to de-
velop a gating strategy to detect the expression of GC markers
and determine B cell populations present in the meningeal
clusters (Fig. 3A). Based on expression of IgM and IgD we found
that the majority of B cells in the spinal cord meninges included
IgM+ IgD− B cells and IgM− IgD− naive mature follicular B
cells (Fig. 3B). While relatively few B cells existed in the CNS
parenchyma, most expressed MHCII. In the spinal cord menin-
ges, where B cells are plentiful, nearly all were MHCII+, in-
dicating a capacity for cognate interactions with CD4 T cells
(Fig. 3C). CD138+ plasmablasts and plasma cells were very rare
in all tissues analyzed but were most frequent in the brain
compared to the spinal cord and spinal cord meninges (Fig. 3C).
The mean frequency of GL7+ GC B cells in the spinal cord
meninges was low, although elevated compared to brain and
spinal cord parenchyma, indicating that most B cells in the CNS
were not undergoing GC-like reactions at this early stage of the
disease (Fig. 3C). Spinal cord specimens stained with both
B220 and the proliferation marker Ki-67 revealed the absence of
costaining (Fig. 3D), demonstrating the formation of B cell
clusters just 3 d following the onset of EAE is likely due to a
large infiltration of B cells rather than proliferation in situ. Some
B cell clusters in the spinal cord meninges were heavily infil-
trated by CD3+ T cells (Fig. 3 E, i, arrows), while T cells were
sparse in other clusters (Fig. 3 E, ii, arrows). In summary, the
spinal cord meninges of Tam-BAPC mice with EAE rapidly de-
veloped dense clusters of activated, class-switched, MHCII+ B
cells, suggesting that this is a critical location for cognate in-
teractions during EAE.
To define the specific anatomical site of B cell infiltration
within the meninges during EAE, we analyzed decalcified spinal
cords harvested from Tam-BAPC mice 3 d after EAE onset using
immunofluorescent staining. We detected B cell extravasation
from the cerebrovasculature which formed clusters surrounding
vascular cell adhesion molecule-1 (VCAM-1)+ activated endo-
thelial cells (Fig. 4 A and B). B cell clusters were excluded from
the spinal cord parenchyma, identified by glial fibrillary acidic
protein (GFAP) staining (Fig. 4B), and pia mater, identified by
laminin (Fig. 4C). Rather, B cell clusters were associated with
the arachnoid mater as seen by Podoplanin-1 staining (Fig. 4 B
and C). Overlays of these immunofluorescent stains revealed
that B cell clusters were specifically in the subarachnoid space,
an anatomical compartment with access to both antigens and
cognate CD4 T cells.
Inflammatory Myeloid Cells Facilitate B Cell Cluster Formation in the
Subarachnoid Space. The mechanisms of B cell localization to the
meninges remain unclear. To understand the kinetics of immune
cell trafficking and B cell cluster formation, the spinal cord
meninges of Tam-WTAPC and Tam-BAPC mice harvested at vari-
ous time points throughout the course of EAE were examined by
flow cytometry. The baseline composition of immune cells was
measured in Tam-WTAPC and Tam-BAPC animals harvested 3 wk








Fig. 2. B cells are organized into extensive clusters in Tam-BAPC mice.
Confocal microscopy of optically cleared spinal cords in vertebrae harvested
around 3 d post EAE onset from Tam-WTAPC (A) and Tam-BAPC (B) mice that
were treated with Tam 3 wk post CD4 T cell transfer. (Left) Images show
cross-section of x, y, and z axes with cross-hairs centered near B cells. Images
show podoplanin+ spinal cord meninges (white), autofluorescent spinal cord
parenchyma and bone tissue (green), and B220+ (red) B cells. Images are
representative of n = 4 cleared spinal cords per genotype, pooled from
3 separate experiments. Arrows indicate B cell clusters. (Scale bar, 500 μm.)
S.C., spinal cord.




















































































































































































































































Fig. 3. B cell clusters in the spinal cord meninges exhibit features of rudimentary ectopic lymphoid follicles after EAE onset. (A) Example flow cytometry
gating strategy generated from hMOG-immunized WT splenocytes harvested 3 d post active EAE onset to detect and quantify the data shown in B and C.
Histogram of B cell MHCII staining is overlaid with shaded histogram of CD11b+ cells. (B) Frequency of IgM− IgD+ B cells, IgM+ IgD+, IgM+ IgD−, and IgM−
IgD− (naive mature follicular B cells) B cells, as a percent of total B cells in the spinal cord meninges of Tam-BAPC mice treated with Tam at week 3 post CD4
T cell transfer and harvested around 3 d post EAE onset. Data generated from n = 11 mice, pooled from 4 separate experiments. (C) Mean frequency with
95% confidence interval of MHCII+ B cells (Left) as a percent of total B cells and of CD138+ B220+ plasma cells (Middle) and IgD− GL7+ GC B cells (Right), out
of the total frequency of CNS mononuclear cell singlets in the brain (squares), spinal cord (triangles), and spinal cord meninges (circles) of Tam-BAPC mice
treated with Tam at week 3 post CD4 T cell transfer and harvested 3 d post EAE onset. Data generated from n = 11 mice, pooled from 4 separate experiments.
(D) B220 (pink), Ki-67 (green), and DAPI (blue) immunofluorescence staining of decalcified spinal cord in the vertebrae of Tam-B
APC mice treated with Tam at
week 3 post CD4 T cell transfer and harvested 3 d post EAE onset. (Left) Tam-BAPC spinal cord imaged at 4× magnification; boxed Insets correspond to 10×
magnification of region of interest. Images are representative of n = 7 mice, pooled from at least 4 separate experiments. (Scale bars, 100 μm.) (E) B220 (red/
pink), CD3 (green), and DAPI (blue) immunofluorescence staining of decalcified spinal cord in the vertebrae of Tam-BAPC mice treated with Tam at week 3 post
CD4 T cell transfer and harvested 3 d post EAE onset. (i and ii, Insets) Single-color images from boxed regions of interest imaged at 10× magnification. Arrows
indicate B and T cell colocalization. Images are representative of n = 7 mice, pooled from at least 4 separate experiments. (Scale bars, 100 μm.)



















































treatment. At 24 and 72 h after induction of MHCII expression, B
cell counts were low in the spinal cord meninges of Tam-WTAPC
mice (Fig. 5A) and Tam-BAPC mice (Fig. 5B). However, by 3 d
post EAE onset, B cells were the most numerous cell type ana-
lyzed (Fig. 5 A and B). Donor T cells were virtually undetectable
in the spinal cord meninges until the onset of EAE symp-
toms for Tam-WTAPC mice (Fig. 5A) and Tam-BAPC mice (Fig.
5B). Strikingly, we observed early and sustained infiltration of
CD45hiCD11bhiGr-1hi inflammatory, granulocytic myeloid cells
in the spinal cord meninges of Tam-BAPC mice but not Tam-
WTAPC mice, a difference that was statistically significant at 24 h
post Tam, 72 h post Tam, and 3 d post EAE onset (Fig. 5C). We
reasoned that these CD45hiCD11bhiGr-1hi inflammatory cells were
most likely polymorphonuclear neutrophils (PMNs), as this cell
type is rapidly recruited to sites of inflammation and infection and
has been detected during initial phases of EAE (21, 22). Imaging of
decalcified spinal cords from Tam-BAPC mice with EAE revealed
the proximity of B cell clusters with Ly6G+ PMNs (SI Appendix,
Fig. S1), consistent with a coordinated influx of PMNs promoting
an environment conducive to B cell antigen presentation and the
rapid establishment of B cell clusters following EAE onset.
Immune Cell Trafficking to the CNS to Induce EAE Is Directed by
Distinct Sequences of Chemokine Regulation in WT and B Cell-
Dependent EAE. We reasoned that identification and quantifica-
tion of the chemokines present in the CSF during the early stages
of EAE induction would provide insight into the previously ob-
served differences in the coordinated trafficking of immune cells
to the CNS in B cell-dependent EAE. CSF was collected from
naive WT mice and pre-Tam Tam-BAPC mice, as well as from
Tam-WTAPC and Tam-BAPC mice at 24 and 72 h post Tam, the
day of EAE onset, 3 d post EAE onset, and 30 d post Tam to
determine the dynamic expression of inflammatory cytokines and
chemokines.
The mean concentrations of analytes observed in naive WT
mice were similar to the levels detected in CSF collected from
Tam-BAPC mice harvested 3 wk post CD4 T cell transfer but
prior to Tam treatment (Fig. 6 A–E), indicating that encephali-
togenic CD4 T cells did not induce inflammatory responses in
the absence of MHCII expression. Tam-WTAPC (red squares)
exhibited higher concentration of IFNγ at 72 h post Tam com-
pared to Tam-BAPC mice (P = 0.006). At the day of EAE onset,
the concentration in Tam-WTAPC mice was still significantly up-
regulated compared to Tam-BAPC mice (P < 0.0001) (Fig. 6A).
Other mediators of inflammation, including CC chemokine li-
gand (CCL)5 and CCL19 within the CSF CCL5 were significantly
different between Tam-WTAPC and Tam-BAPC mice (Fig. 6 B and
C). Drastically different concentrations of the CXC glutamate-
leucine-arginine (ELR)+ chemokines CXCL5, CXCL2, and
CXCL1 were identified in the CSF of Tam-WTAPC and Tam-BAPC
mice at the same stages of disease. Tam-WTAPC mice tended to
rapidly develop much higher concentrations of these chemokines
than Tam-BAPC mice (Fig. 6D).
Given the significance of CXCL13 for B cell trafficking and
GC reactions, differences in the concentration of this chemokine
between Tam-WTAPC and Tam-BAPC mice could provide insight
into the progression of B cell cluster formation. Although a
substantial increase in concentration was observed in both groups,
the only difference was identified, at 3 d post EAE onset, with
Tam-WTAPC mice exhibiting significantly lower CXCL13 con-
centrations compared to Tam-BAPC mice (Fig. 6E).
The variability in chemokine concentrations in the CSF between
Tam-WTAPC mice and Tam-BAPC mice, especially at 72 h post
Tam, could explain our observation that these 2 genotypes differ in
CB
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Fig. 4. B cell clusters form in the subarachnoid space adjacent to activated endothelial vasculature. Tam-BAPC mice were treated with Tam at week 3 post CD4
T cell transfer and killed 3 d post EAE onset. (A, Left) Decalcified spinal cords were stained for B220 (pink), CD3 (green), and DAPI (blue) and imaged at 4×
magnification. (A, Right) Boxed insets are regions of interest (from left) stained for activated endothelial cells (VCAM-1, red), astrocytes (GFAP, green), and
DAPI (blue) and imaged at 10×magnification. (B, Left, Top, and Bottom) Overlays of single-color images displayed at Right. (i) GFAP (green), (ii) VCAM-1 (red),
(iii) DAPI (blue), and (iv) podoplanin-1 (white). (C) Serial sections of the spinal cord shown in B. (Left, Top, and Bottom) Overlay images of single-color images
displayed at Right. (i) Laminin (green), (ii) B220 (red), (iii) DAPI (blue), and (iv) podoplanin-1 (white). All images are representative of n = 7 mice, pooled from
at least 4 separate experiments. (Scale bars, 100 μm.)







































































CD45hiCD11bhiGr-1hi inflammatory PMN invasion of the spinal
cord meninges (Fig. 5C). These ELR+ CXC chemokines all share
the receptor CXC chemokine receptor (CXCR)2, which is pre-
dominantly expressed by PMNs. In Tam-BAPC mice 72 h post Tam,
CXCR2 expression was detected in splenic CD45hiCD11bhiGr-1hi
inflammatory PMN cells, but not on PMNs isolated from the
meninges (Fig. 6F). However, 3 d post EAE onset, PMN ex-
pression of CXCR2 in the spinal cord meninges was notably higher
(Fig. 6F). B cells did not express CXCR2 in any tissue at any time
point examined (Fig. 6F). Further flow cytometric analysis of the
phenotype of CD45hiCD11bhiGr-1hi inflammatory PMNs in the
spinal cord meninges of Tam-BAPC mice confirmed minimal
contamination with Ly6C+ monocytes (SI Appendix, Fig. S2).
Between 72 h post Tam and 3 d post EAE onset, PMNs isolated
from the spinal cord meninges exhibited signs of activation with a
reduction in surface expression of CD62L coinciding with in-
creased CXCR2 (SI Appendix, Fig. S2). These data are corrobo-
rated by reports that transmigration of the blood–brain barrier
(BBB) induces enhanced inflammatory phenotypes in PMNs (23).
Overall, the data indicate that B cell-dependent EAE promotes a
unique inflammatory signaling cascade resulting in the CXCR2-
directed recruitment of PMNs at temporally regulated stages
of disease.
Early PMN Recruitment to the CNS Is Required for the Formation of
Meningeal B Cell Clusters and Development of EAE. Modulating
CXCR2 signaling with anti-CXCR2 antibodies or small-molecule
competitive antagonism has been shown to alter the site of
neuroinflammation and the composition of inflammatory infiltrates
during EAE and can even modulate the expression of disease
symptoms to protect mice from atypical EAE induced by Th17















































































































































































































































































































* ** Tam-B cell
APC
Tam-WTAPC
Fig. 5. Coordinated trafficking of inflammatory myeloid cells precedes B cell infiltration in B cell-dependent EAE. (A–C) Box and whiskers plots showing
mean and 10 to 90th percentile data points generated from the frequency (Left) and absolute number (Right) of B cells (maroon circles), Gr-1+ PMNs (black
squares), and donor CD4 T cells (green triangles) in the spinal cord meninges of Tam-BAPC mice harvested at 3 wk post T cell transfer and before Tam
treatment or from Cre- littermates of Tam-BAPC mice harvested at 3 wk post T cell transfer. Data generated from n = 15 mice, pooled from at least 4 separate
experiments. (A) Box and whiskers plots showing mean and min/max data points generated from the frequency (Left) and absolute number (Right) of B cells
(maroon circles), Gr-1+ PMNs (black squares), and donor CD4 T cells (green triangles) in the spinal cord meninges of Tam-WTAPC mice harvested at various time
points in disease. Data are generated from n = 8 to 12 mice per time point, pooled from at least 10 separate experiments. (B) Box and whiskers plots showing
mean and 10 to 90th percentile data points generated from the frequency (Left) and absolute number (Right) of B cells (maroon circles), Gr-1+ PMNs (black
squares), and donor CD4 T cells (green triangles) in the spinal cord meninges of Tam-BAPC mice harvested at various time points in disease. Data generated
from n = 11 to 16 mice, pooled from at least 10 different experiments. (C) Box and whiskers plots showing mean and all data points for frequency (Left) and
absolute number (Right) of Gr-1+ PMNs harvested from the spinal cord meninges of Tam-WTAPC mice (red) and Tam-BAPC mice (blue) killed at various time
points in disease course. Statistical significance was determined by 2-tailed Mann–Whitney U tests. Exact P values calculated, *P < 0.05, **P < 0.01.



















































of PMNs to the CNS was functionally relevant to EAE dependent
on B cell antigen presentation, we neutralized CXCR2 in Tam-BAPC
mice. Anti-CXCR2 serum was administered after encephali-
togenic CD4 T cells were transferred into Tam-BAPC mice but
prior to MHCII induction 3 wk later. The disease severity as
represented by total area under the curve of mean disease scores
was similar for mice receiving control serum and untreated control
mice (Fig. 7A). Mice treated with anti-CXCR2 blocking antibody
did not develop EAE as quickly or as severely as the control groups
(Fig. 7A). Examination of immunofluorescence images indicates
that B cell clusters were present in the spinal cord meninges of
both control groups, but were not detected in mice treated with
anti-CXCR2 serum (Fig. 7B), suggesting that meningeal B cell
cluster formation is pathogenic for EAE dependent on B cell an-
tigen presentation. By flow cytometry, donor T cells in the spinal
cord meninges of anti-CXCR2–treated mice compared to un-
treated or control serum groups were similar (SI Appendix, Fig. S3
A and B). As well, B cells and MHCII+ B cells were found in
similar numbers in the spleen of anti-CXCR2 mice compared to
control groups (SI Appendix, Fig. S3C). However, in accordance
with the absence of meningeal B cell clusters observed 3 d post
EAE onset, there were very few B cells in the spinal cord meninges
of anti-CXCR2–treated mice (SI Appendix, Fig. S3D). Our findings
suggest that interrupting CXCR2 signaling by PMNs diminished
the ability of B cells to access the CNS, a step that may be required
for B cell APCs to support EAE.
B Cell Access to the Subarachnoid Space Is Necessary for B Cell
Antigen Presentation to Support Passive EAE. Based on the obser-
vation that EAE was ameliorated and B cell clusters were absent
in anti-CXCR2–treated mice, we hypothesized that entry into the
CNS compartment was required for B cell antigen presentation to
induce neuroinflammation. To test this, CD19-BMHCIIxIgHMOG
and Tam-BAPC mice were crossed to mice in which the gene
encoding the α4 integrin of the VLA-4 molecule is flanked by
LoxP (f/f) sites (VLA-4f/f mice). Protein expression changes were
verified in peripheral blood B cells from Tam-BAPC mice prior to
Tam treatment and 72 h post Tam treatment (Fig. 7C). WT and
Cre−VLA-4f/f mice with WT VLA-4 expression levels were both
susceptible to EAE (SI Appendix, Table S1) with a similar day of
onset and disease severity (Fig. 7 D, Top). CD19-BMHCIIxIgHMOG
mice and CD19-BMHCIIxIgHMOGxVLA-4f/+ mice were susceptible
to EAE, but CD19-BMHCIIxIgHMOGxVLA-4f/f mice were com-
pletely protected (Fig. 7 D, Center). We repeated the passive EAE
experiment with Tam-BAPC, Tam-BAPCxVLA-4f/+, and Tam-BAPC
xVLA-4f/f mice and treated them with Tam at 3 wk post-
















































































































































































































































































































100 101 102 103 100 101 102 103
3 days post onset 
Spleen SC meninges
72hr post Tam
100 101 102 103100 101 102 103
Spleen SC meninges
CXCR2
Fig. 6. Temporal regulation of chemokine expressionmediates immune cell recruitment to the CNS. (A–E) Graphs show box and whiskers plots with min-to-max
error bars of concentrations for (A) IFN-γ; (B) RANTES/CCL5; (C) MIP3-β/CCL19; (D) (Left) CXCL5, (Middle) CXCL2, (Right) CXCL1; and (E) CXCL13 detected in the CSF
of naive WT (black), Tam-WTAPC (red) and Tam-BAPC (blue) mice harvested at various time points in EAE disease course. Statistical significance was determined by
2-tailed Mann–Whitney U tests. Exact P values calculated, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (F) Flow cytometric analysis of CXCR2 expression
on PMNs (gray histograms) and B cells (blue histograms) isolated from the spleen (Left) and spinal cord meninges (Right) of Tam-BAPC mice collected at 72 h post
Tam (Left two panels) and 3 d post EAE onset (Right two panels). Graphs are representative of n = 4 to 5 mice, pooled from 2 separate experiments.







































































and heterozygous expression of VLA-4 in B cells were susceptible
to EAE with similar severity and day of onset, while mice devoid
of B cell VLA-4 expression were completely protected (Fig. 7 D,
Bottom). Examination of spinal cords by immunofluorescence
confirmed that Tam-BAPC mice and Tam-BAPCxVLA-4f/+ mice
with EAE both developed substantial clusters of B cells in the
spinal cord meninges, while the deletion of B cell VLA-4
expression prevented B cells from entering the subarachnoid
space by extravasation through VCAM-1+ blood vessels (SI Ap-
pendix, Fig. S4). These results demonstrate the requirement for B
cell VLA-4 expression for access to the CNS compartment and
antigen presentation function during EAE.
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Fig. 7. Granulocyte recruitment to the CNS and VLA-4–dependent B cell access to the subarachnoid space are necessary for formation of B cell clusters and B
cell antigen presentation to support passive EAE. (A) (Left) EAE scores ± SEM for Tam-BAPC mice from the untreated group (blue circles), control serum group
(black circles), and anti-CXCR2 recipients (white circles). Arrows indicate day of treatment. Significance determined by calculating the area under curve of
mean disease scores. Graph is representative of n = 3 separate experiments with at least n = 4 mice per group. (Middle) Mean day of EAE onset ± SEM for
Tam-BAPC mice from the untreated group (blue circles), control serum group (black circles), and anti-CXCR2 recipients (white circles). Data are pooled from n =
3 separate experiments with at least n = 4 mice per group. Significance determined by Kruskal-Wallis ANOVA test with Dunn’s correction for multiple
comparisons. P = n.s. for untreated vs. control serum groups, ***P < 0.001 for untreated vs. anti-CXCR2 groups, and **P = 0.0096 for control serum vs. anti-
CXCR2 groups. (Right) Graph of EAE incidence for Tam-BAPC mice from the untreated group (blue line), control serum group (black line), and anti-
CXCR2 recipients (dotted black line). Data are pooled from n = 3 separate experiments with at least n = 4 mice per group. Significance evaluated by log-
rank test, ****P < 0.0001. (B) Decalcified Tam-BAPC spinal cord stained for (Left) B220 (pink), GFAP/podoplanin-1 (green), and DAPI (blue), imaged at 10×
magnification. (Scale bars, 100 μm.) (C) Peripheral blood B cell expression of MHCII (Top) and VLA-4 (Bottom) prior to Tam treatment (black histograms) and
72 h post Tam (blue histograms). Plots are representative of at least n = 10 mice tested at both time points, pooled from more than 4 independent ex-
periments. (D) (Left) Mean EAE scores ± SEM; (Right) mean day of EAE onset. (Top) Graphs of WT (black squares) and Cre-VLA-4f/f (white circles) are rep-
resentative of 3 independent experiments with n = 3 to 11 mice per genotype. (Center) Graphs of BMHCIIxIgHMOG (black squares), BMHCIIxIgHMOGxVLA-4f/+ (blue
and white circles), and BMHCIIxIgHMOGxVLA-4f/f mice (white circles) are representative of 5 independent experiments with n = 3 to 8 mice per genotype.
Statistical significance for the day of onset determined by t test. P = n.s. (Bottom) Graphs of Tam-BAPC mice (blue squares), Tam-BAPCxVLA-4f/+ (blue and white
circles), and Tam-BAPCxVLA-4f/f mice (white circles) are representative of 6 independent experiments with n = 3 to 8 mice per genotype. Statistical significance
for the day of onset determined by t test. P = n.s.




















































While cognate interactions between B cells and CD4 T cells are
known to be important for autoantibody formation in MS, the
nature and location of these pathogenic interactions in EAE are
unclear. Similarly, the genesis of ELT within the meninges of pa-
tients with progressive MS is thought to be clinically relevant, but
the mechanisms leading to the formation of these structures re-
main unknown. We sought to determine the sequence of proin-
flammatory events that fosters the formation of antigen-specific B
and T cell interactions within the CNS intrinsic to the clinico-
pathologic features of MS. We have found that the subarachnoid
space of the spinal cord meninges serves as a niche for B cell
cluster formation during EAE. This is corroborated by other re-
ports of ELT in EAE, including Dang et al. (26), who found
nonclassically activated B cells in the spinal cord meninges of
TCRMOGxIgHMOG mice with spontaneous EAE. In our model, we
found a high frequency of MHCII+ B cells that frequently
exhibited surface markers such as IgM+ IgD− B cells (27) and
naive follicular B cells. The low frequency of CD138+ plasma cells
or plasmablasts and few GL7+ GC B cells we observed in the
spinal cord meninges can be accounted for by the early time points
used in this study. One caveat to these results is that CD138
staining can be challenging based on the lack of stability of this
surface marker during processing for flow cytometry, leading to a
potential underestimation of the number of plasma cells/plasma-
blasts. Also, it is important to note that the encephalitogenic do-
nor CD4 T cell lines used to induce passive EAE in our model are
very strongly Th1-skewed and thus distinct from models exhibiting
ELT in B6 or SJL (Swiss Jim Lambert) mice involving IL-17–
skewed CD4 T cells (12, 18). This is relevant, given that prior
work has shown that Th17 cells are capable of trafficking to the
CNS during EAE without expression of VLA-4 (28). Additionally,
donor T cells driving disease in our model may not be capable of
functioning as efficient T follicular helper cells to sustain GC re-
actions. These explanations are not mutually exclusive and deserve
further exploration to elucidate the critical mechanisms involved
in transitions from immature to established ELT structures
in EAE.
To explore the factors recruiting and retaining B cells to the
subarachnoid space to the exclusion of other CNS tissues we
investigated the kinetics of innate and adaptive immune cell
trafficking at several stages of EAE progression. Prior to EAE
onset, CD45hiCD11bhiGr-1hi PMNs are the most common cell
type observed in the spinal cord meninges of Tam-WTAPC and
Tam-BAPC mice. This proinflammatory cell type is often a major
component of early inflammatory infiltrates in EAE (22, 29, 30),
and it is especially elevated in Tam-BAPC mice compared to
Tam-WTAPC mice. PMNs may be playing a unique role in the
early stages of B cell-dependent EAE in which they prime the
CNS microenvironment for B cell cluster formation through
activating the endothelium or compromising the integrity of the
BBB (29, 31). It is possible that PMN transmigration of the BBB
results in the up-regulation of VCAM-1 or CXCL13 to promote
B cell extravasation into the subarachnoid space. Indeed, pe-
ripheral blood isolated from MS patients is enriched for neu-
trophil extracellular traps (NETs), which are a potent source of
antigens and activation signals for autoreactive B cells in sys-
temic lupus erythematosus (SLE) (32–34). Utilizing our unique
ability to sample murine CSF, we decided to target CXCR2 as a
means of testing our hypothesis that PMN trafficking is essential
for B cell recruitment to the spinal cord meninges and initial
ELT formation. CXCR2 expression was restricted to PMNs in
Tam-BAPC mice, and over time, PMNs harvested from the spinal
cord meninges of these mice exhibited surface markers indicative
of increased activation. We have found that treating Tam-BAPC
with anti-CXCR2 serum delays the day of EAE onset and
resulted in less severe EAE symptoms, consistent with previous
studies showing antagonism of CXCR2 signaling protects from
neuroinflammation (24, 25, 35). Ameliorated EAE in anti-
CXCR2 recipients was associated with complete ablation of B
cell clusters in the subarachnoid space as well as changes in the
tissue distribution of PMNs. The involvement of PMNs in neu-
roinflammation, both in MS as well as MS-related diseases, is
complex. In our model of B cell-dependent EAE, PMN migra-
tion to the CNS is required for B cell antigen presentation
function and the development of clinical disease. This does not
necessarily indicate that CXCR2-dependent PMN migration is
critical to the development of EAE in WT mice due to B cell
antigen presentation. Rather, when APC function is isolated to B
cells, our data indicate that the process by which B cells accu-
mulate within the meninges is PMN-dependent. Overall, inhib-
iting the ability of PMNs to respond to timely expression of
CXCR2 ligands in our model impedes formation of B cell clus-
ters, potentially due to reductions in PMN-secreted proin-
flammatory cytokines, less PMN-induced damage to the BBB,
and/or inhibited induction of other chemokines that promote the
recruitment of other immune cells.
In conclusion, our research indicates that B cell clusters in the
spinal cord subarachnoid space are aggregates of immune cells
engaging in pathogenic, antigen-specific interactions. Formation
of these rudimentary meningeal ELT in Tam-BAPC mice is essen-
tial for B cell antigen presentation to support neuroinflammation.
Prior to the onset of EAE and well before B cell cluster formation,
PMNs are recruited to the CNS by ELR+ CXC chemokines. In-
hibition of CXCR2-mediated PMN trafficking to the CNS reduces
pathogenic B cell clusters, suggesting that PMN recruitment primes
the CNS compartment for B cell cluster formation. Therapeutic
targeting of CXCR2 signaling could be effective for MS, and more
research is needed to investigate the possibility of direct or indirect
interactions between PMNs and B cells. In accordance with successful
therapies that eliminate B cells (BCDTs) or prevent immune cell
trafficking to the CNS (Natalizumab or Fingolimod), B cell-restricted
VLA-4 deficiency inhibits the development of EAE symptoms when
B cells are the only APCs. Coordinated trafficking of innate and
adaptive immune cells may promote EAE by supporting VLA-4–
dependent B cell accumulation within the meninges during neuro-
inflammation. Future experiments aimed at determining whether B
cell access to the CNS is necessary for antigen acquisition or pre-
sentation to CD4 T cells will be essential in refining cellular immune
therapeutic targeting with distinct CNS compartments in mind.
Materials and Methods
Mice. Mice were housed in a single pathogen-free housing facility and fed
mouse chow and water ad libitum. Male and female mice between 6 and
10 wk of age were used for all experiments with the exception of the anti-
CXCR2 treatment experiments that utilized female mice exclusively. Further
information regarding strains and breeding is available in SI Appendix.
EAE. Passive EAE was induced as previously reported (6) and is described in
more detail in SI Appendix. For induction of MHCII in vivo, Tam-WTAPC, Tam-
BAPC, and Tam-BAPC xVLA-4f/f or Tam-BAPC xVLA-4f/+ mice were treated with 5 μg
Tam (Sigma-Aldrich) in 50 μL corn oil (Sigma-Aldrich) by oral gavage 3 wk
after CD4 T cell transfer as described (20). MHCII and VLA-4 expression was
verified by flow cytometric analysis of peripheral blood. The Animal Studies
Committee/Institutional Animal Care and Use Committee of Washington
University in St. Louis approved all animal experiments.
In Vivo CXCR2 Neutralization. Rabbit anti-mouse CXCR2 serum was generated
according to previous reports (24) and 0.2-μm vacuum-filtered. Control
polyclonal rabbit serum (R4505, Sigma-Aldrich) was sterilized with 0.45-μm
syringe filters (TPP). Age-matched female Tam-BAPC mice were injected in-
traperitoneally with 200 μL control or anti-CXCR2 serum on days −2, 0, 2, and
4 relative to Tam treatment by oral gavage (at day 0) 3 wk after CD4 T cell
transfer. Mice were scored daily for clinical disease and killed 3 d post EAE
onset or 13 to 15 d post Tam.







































































Flow Cytometry. Isolation and staining of single cells from various tissues for
flow cytometric analysis was preformed according to prior reports (6) and is
detailed in SI Appendix.
CSF Collection and Analysis. Mice were avertin-anesthetized prior to CSF
collection from the cisterna magna. CSF was stored in MAXYMum Recovery,
low-protein-binding PCR tubes and immediately spun down and frozen.
Concentration of cytokines and chemokines was assessed using the BioRad
33-plex kit analyzed on a Luminex. Concentrations of CSF were transformed
logarithmically for graphing and statistical analysis purposes.
Imaging. Immunofluorescence staining for CD3 and B220 was performed as
previously reported (6). Intermittent background labeling from anti-CD3
staining was noted, but consistently within the gray matter and not in a
pattern confounding for cellular labeling of T cells. Background immunoflu-
orescence was a result of anti-CD3, as control staining with secondary antibody
only never resulted in excessive background signal. Staining for additional
markers, including VCAM-1, Ly-6G, podoplanin, and Ki-67 is detailed in SI Ap-
pendix. Optical clearing of spinal cords was initiated by perfusing mice with 25mL
ice-cold phosphate buffered saline followed by 20 mL 4% paraformaldehyde
(Sigma-Aldrich). CNS tissue was extracted while still encased in the skull and
vertebral column, then fixed in 4% paraformaldehyde for more than 12 h. Spinal
cord vertebrae were decalcified in 6% tricholoroacetic acid (Sigma-Aldrich) for
5 d and washed with PBS prior to optical clearing using iDISCO protocol (36).
Additional details including confocal imaging are provided in SI Appendix.
Data Availability. All data discussed in the paper are available via Figshare,
https://doi.org/10.6084/m9.figshare.10052051.v1.
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